SALIVARY BIOMARKERS FOR NON-INVASIVE DETECTION OF ORAL POTENTIALLY MALIGNANT DISORDERS (OPMDS)

Main Article Content

Dr Syeda Rabia Rahat Gilani
Dr Rafey Ahmad Jameel
Dr Wajahat Ghafoor Chaudhary
Dr Ammar Abdullah Malik
Dr Shah Salman Khan
Dr Qaiser Masud Sheikh

Keywords

Oral Potentially Malignant Disorders, Salivary Biomarkers, Non-invasive Diagnosis, IL-6, LDH, MicroRNA

Abstract

Introduction: Oral Potentially Malignant Disorders (OPMDs) are potentially malignant disorders because they may convert into oral cancer. Timely detection of health problems, without surgery, helps patients to recover faster. Salivary biomarkers are popular for testing because they are easy to obtain and cause little discomfort.


Objective: To evaluate the efficacy of salivary biomarkers for non-invasive detection of OPMDs in patients attending different hospitals in Pakistan.


Materials and Method: A prospective case-control study was conducted from March 2024 to August 2024 with 100 participants. Saliva samples were collected and analyzed for biomarkers including IL-6, LDH, and specific microRNAs using ELISA and RT-PCR techniques.


Results: Significant elevation of IL-6, LDH, and certain microRNAs was observed in OPMD patients compared to healthy controls (p < 0.05), demonstrating high sensitivity and specificity for detecting potentially malignant lesions.


Conclusion: Salivary biomarkers represent a valuable, non-invasive diagnostic tool for early identification of OPMDs, potentially enabling timely intervention and reducing oral cancer incidence.

Abstract 100 | pdf Downloads 45

References

1. Piyarathne, N.S., Rasnayake, R.M.S.G.K., Angammana, R., Chandrasekera, P., Ramachandra, S., Weerasekera, M., Yasawardene, S., Abu-Eid, R., Jayasinghe, J.P. and Gupta, E., 2021. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors–A systematic review. Expert Review of Molecular Diagnostics, 21(8), pp.789-807.
2. López-Jornet, P., Olmo-Monedero, A., Peres-Rubio, C., Pons-Fuster, E. and Tvarijonaviciute, A., 2023. Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case–Control Study. Cancers, 15(21), p.5256.
3. Salwaji, S., Pasupuleti, M.K., Manyam, R., Pasupuleti, S., Uzunçıbuk, H., Russo, D., Cervino, G., Marrapodi, M.M. and Minervini, G., 2025. Innovative technologies for identifying oral potentially malignant disorders: a systematic review. Exploration of Medicine, 6, p.1001315.
4. Suragimath, G., Patil, S. and Suragimath, D.G., 2024. Salivaomics: A Revolutionary Non-invasive Approach for Oral Cancer Detection. Cureus, 16(11).
5. Rapado-González, Ó., Salta, S., López-López, R., Henrique, R., Suárez-Cunqueiro, M.M. and Jerónimo, C., 2024. DNA methylation markers for oral cancer detection in non-and minimally invasive samples: a systematic review. Clinical Epigenetics, 16(1), p.105.
6. Rebaudi, F., Rebaudi, A., De Rosa, A., Rebaudi, A.L., Pesce, S., Greppi, M., Roghi, M., Boggio, M., Candiani, S. and Marcenaro, E., 2024. Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders-Insights from a case-control study. Frontiers in Immunology, 15, p.1477477.
7. Rajeev, R., Somanathan, A. and Choudhary, K., 2024. An overview of advanced diagnostic techniques for early detection of oral potentially malignant disorders and oral squamous cell carcinoma. Journal of Dentistry Defense Section, 18(1), pp.21-26.
8. Zareef, U., Ahmed, T. and Khero, R., 2023, October. Evaluation of Salivary Biomarkers for Early Detection of Oral Potentially Malignant Disorders: A Prospective Study. In Medical Forum Monthly (Vol. 34, No. 10).
9. Mazumder, S., Basu, B., Ray, J.G. and Chatterjee, R., 2023. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients. Archives of oral biology, 147, p.105627.
10. Nazar, N.S.B.M., Ramanathan, A., Ghani, W.M.N., Rokhani, F.B., Jacob, P.S., Sabri, N.E.B., Hassan, M.S., Kadir, K. and Dharmarajan, L., 2024. Salivary metabolomics in oral potentially malignant disorders and oral cancer patients—a systematic review with meta-analysis. Clinical Oral Investigations, 28(1), p.98.
11. Bastías, D., Maturana, A., Marín, C., Martínez, R. and Niklander, S.E., 2024. Salivary biomarkers for oral cancer detection: an exploratory systematic review. International Journal of Molecular Sciences, 25(5), p.2634.
12. Pierfelice, T.V., D’Amico, E., Cinquini, C., Iezzi, G., D’Arcangelo, C., D’Ercole, S. and Petrini, M., 2024. The diagnostic potential of non-invasive tools for oral cancer and precancer: a systematic review. Diagnostics, 14(18), p.2033.
13. Mishra, B.P. and Patil, D.V., 2025. A comparative study to evaluate salivary biomarker interleukin-6 in oral squamous cell carcinoma and oral potentially malignant disorders. Cuestiones de Fisioterapia, 54(2), pp.864-868.
14. Muthu, K. and Dorairaj, J., 2022. Human Salivary microRNA as Biomarkers in Oral Potentially Malignant Disorder-A Narrative Review. Journal of Young Pharmacists, 14(2), p.156.
15. Dikova, V., Jantus-Lewintre, E. and Bagan, J., 2021. Potential non-invasive biomarkers for early diagnosis of oral squamous cell carcinoma. Journal of Clinical Medicine, 10(8), p.1658.
16. Shah, F.Y., Shetty, D.C., Kaur, G., Gupta, S., Pathak, A. and Aggarwal, V., 2023. Serum and saliva LDH levels in patients with habit, oral potentially malignant disorders (OPMDs), and oral squamous cell carcinoma (OSCC): a spectrophotometry study. Journal of Pharmacy and Bioallied Sciences, 15(Suppl 2), pp.S881-S884.

Most read articles by the same author(s)